We are developing radiotracers for early detection of neurodegenerative disorders. This diagnosis is performed using PET imaging to visualize specific brain receptors. We see Nemosia as the missing piece to support drug development, therapy monitoring patient recruitment.

Location
Canton
Facts & figures
  • Type of organization
    Private company
  • Year of foundation
    2022
  • Number of employees in Switzerland
    1-9

You may also be interested in